ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,13 € ↓ -0,04 (-0,65%)
2026-06-03
AKTIENPREIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership4,018,869 shares
Latest Disclosed Value $ 30,824,725
Morgan Stanley reports 21.29% decrease in ownership of 26CA / ImmunityBio, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 4,018,869 shares of ImmunityBio, Inc. (DE:26CA) valued at $26,363,781 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 5,106,214 shares of ImmunityBio, Inc.. This represents a change in shares of -21.29% during the quarter. The current value of the position is $24,635,667 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNITYBIO COM 45256X103 4,018,869 -1,087,345 -21.29 30,825 204.89 0.0019
2026-05-27 2025-12-31 13F/A-1 IMMUNITYBIO COM 45256X103 5,106,214 1,732,644 51.36 10,110 21.84 0.0006
2026-02-13 2025-12-31 13F IMMUNITYBIO COM 45256X103 5,106,214 1,732,644 10,110 0.0006
2026-05-27 2025-09-30 13F/A-1 IMMUNITYBIO COM 45256X103 3,373,570 401,301 13.50 8,299 5.76 0.0005
2025-11-14 2025-09-30 13F IMMUNITYBIO COM 45256X103 3,373,570 401,301 8,299 0.0005
2025-08-15 2025-06-30 13F IMMUNITYBIO COM 45256X103 2,972,269 1,077,135 56.84 7,847 37.55 0.0005
2025-05-15 2025-03-31 13F IMMUNITYBIO COM 45256X103 1,895,134 -2,110,680 -52.69 5,704 -44.37 0.0004
2025-05-15 2024-12-31 13F/A-1 IMMUNITYBIO COM 45256X103 4,005,814 1,758,922 78.28 10,255 22.68 0.0007
2025-02-14 2024-12-31 13F IMMUNITYBIO COM 45256X103 4,005,814 1,758,922 10,255 0.0007
2025-05-14 2024-09-30 13F/A-2 IMMUNITYBIO COM 45256X103 2,246,892 1,678,491 295.30 8,358 132.68 0.0006
2025-02-14 2024-09-30 13F/A-1 IMMUNITYBIO COM 45256X103 2,246,892 1,678,491 8,358 0.0006
2024-11-14 2024-09-30 13F IMMUNITYBIO COM 45256X103 2,246,892 1,678,491 8,358 0.0006
2025-05-14 2024-06-30 13F/A-2 IMMUNITYBIO COM 45256X103 568,401 -56,200 -9.00 3,592 7.10 0.0003
2024-10-17 2024-06-30 13F/A-1 IMMUNITYBIO COM 45256X103 568,401 -56,200 3,592 0.0003
2024-08-14 2024-06-30 13F IMMUNITYBIO COM 45256X103 568,401 -56,200 3,592 0.0003
2024-10-17 2024-03-31 13F/A-2 IMMUNITYBIO COM 45256X103 624,601 24,883 4.15 3,354 11.43 0.0003
2024-08-16 2024-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 624,601 24,883 3,354 0.0003
2024-05-15 2024-03-31 13F IMMUNITYBIO COM 45256X103 624,601 24,883 3,354 0.0003
2024-08-16 2023-12-31 13F/A-1 IMMUNITYBIO COM 45256X103 599,718 201,817 50.72 3,011 347.92 0.0003
2024-02-13 2023-12-31 13F IMMUNITYBIO COM 45256X103 599,718 201,817 3,011 0.0003
2023-11-15 2023-09-30 13F IMMUNITYBIO COM 45256X103 397,901 47,254 13.48 672 -31.01 0.0001
2023-08-14 2023-06-30 13F IMMUNITYBIO COM 45256X103 350,647 -223,119 -38.89 975 -6.70 0.0001
2023-05-15 2023-03-31 13F IMMUNITYBIO COM 45256X103 573,766 29,608 5.44 1,044 -62.15 0.0001
2023-02-14 2022-12-31 13F IMMUNITYBIO COM 45256X103 544,158 -97,655 -15.22 2,759 -13.54 0.0003
2022-11-14 2022-09-30 13F IMMUNITYBIO COM 45256X103 641,813 -336,830 -34.42 3,190 -12.39 0.0004
2022-10-27 2022-06-30 13F/A-1 IMMUNITYBIO COM 45256X103 978,643 -94,876 -8.84 3,641 -39.55 0.0005
2022-08-15 2022-06-30 13F IMMUNITYBIO COM 45256X103 978,643 -94,876 3,641 0.0001
2022-10-27 2022-03-31 13F/A-1 IMMUNITYBIO COM 45256X103 1,073,519 640,695 148.03 6,023 128.84 0.0008
2022-05-13 2022-03-31 13F IMMUNITYBIO COM 45256X103 1,073,519 640,695 6,023 0.0008
2022-02-14 2021-12-31 13F IMMUNITYBIO COM 45256X103 432,824 -64,900 -13.04 2,632 -45.72 0.0003
2021-11-15 2021-09-30 13F IMMUNITYBIO COM 45256X103 497,724 9,434 1.93 4,849 -30.46 0.0007
2021-08-23 2021-06-30 13F/A-1 IMMUNITYBIO COM 45256X103 488,290 155,215 46.60 6,973 -11.81 0.0009
2021-08-16 2021-06-30 13F IMMUNITYBIO COM 45256X103 488,290 155,215 6,973 0.0002
2021-05-17 2021-03-31 13F IMMUNITYBIO COM 45256X103 333,075 13,186 4.12 7,907 85.39 0.0012
2021-02-16 2020-12-31 13F NANTKWEST COM 63016Q102 319,889 63,462 24.75 4,265 139.88 0.0007
2020-11-13 2020-09-30 13F NANTKWEST COM 63016Q102 256,427 -26,053 -9.22 1,778 -48.75 0.0003
2020-08-14 2020-06-30 13F NANTKWEST COM 63016Q102 282,480 216,945 331.04 3,469 1,735.45 0.0008
2020-05-26 2020-03-31 13F/A-1 NANTKWEST COM 63016Q102 65,535 55,428 548.41 189 397.37 0.0001
2020-05-15 2020-03-31 13F NANTKWEST COM 63016Q102 65,535 55,428 189 14.5191
2020-02-14 2019-12-31 13F NANTKWEST COM 63016Q102 10,107 173 1.74 38 216.67 0.0000
2019-11-14 2019-09-30 13F NANTKWEST COM 63016Q102 9,934 -38,563 -79.52 12 -76.00 0.0000
2019-08-14 2019-06-30 13F NANTKWEST COM 63016Q102 48,497 36,486 303.77 50 163.16 0.0000
2019-05-15 2019-03-31 13F NANTKWEST COM 63016Q102 12,011 -53,198 -81.58 19 -75.00 0.0000
2019-02-14 2018-12-31 13F NANTKWEST COM 63016Q102 65,209 -39,193 -37.54 76 -80.26 0.0000
2019-04-23 2018-09-30 13F/A-2 NANTKWEST COM 63016Q102 104,402 -115,999 -52.63 385 -42.88 0.0001
2018-11-20 2018-09-30 13F/A-1 NANTKWEST COM 63016Q102 104,402 0 385 0.0001
2018-11-14 2018-09-30 13F NANTKWEST COM 63016Q102 104,402 -115,999 385
2019-04-23 2018-06-30 13F/A-1 NANTKWEST COM 63016Q102 220,401 23,206 11.77 674 -12.13 0.0002
2018-08-14 2018-06-30 13F NANTKWEST COM 63016Q102 220,401 23,206 674
2019-04-23 2018-03-31 13F/A-1 NANTKWEST COM 63016Q102 197,195 88,590 81.57 767 57.17 0.0002
2018-05-14 2018-03-31 13F NANTKWEST COM 63016Q102 197,195 88,590 767
2019-04-23 2017-12-31 13F/A-1 NANTKWEST COM 63016Q102 108,605 46,425 74.66 488 43.11 0.0001
2018-02-14 2017-12-31 13F NANTKWEST COM 63016Q102 108,605 46,425 488
2017-11-14 2017-09-30 13F NANTKWEST COM 63016Q102 62,180 24,886 66.73 341 20.92 0.0001
2017-08-11 2017-06-30 13F NANTKWEST COM 63016Q102 37,294 1,664 4.67 282 122.05 0.0001
2017-05-22 2017-03-31 13F/A-1 NANTKWEST COM 63016Q102 35,630 -32,814 -47.94 127 -67.60 0.0000
2017-05-12 2017-03-31 13F NANTKWEST COM 63016Q102 35,630 127
2017-02-22 2016-12-31 13F/A-1 NANTKWEST COM 63016Q102 68,444 48,958 251.25 392 159.60 0.0001
2017-02-13 2016-12-31 13F NANTKWEST COM 63016Q102 68,444 392
2016-11-10 2016-09-30 13F NANTKWEST COM 63016Q102 19,486 -6,681 -25.53 151 -7.36 0.0001
2016-08-12 2016-06-30 13F NANTKWEST COM 63016Q102 26,167 10,619 68.30 163 27.34 0.0001
2016-05-12 2016-03-31 13F NANTKWEST COM 63016Q102 15,548 8,842 131.85 128 9.40 0.0000
2016-02-09 2015-12-31 13F NANTKWEST COM 63016Q102 6,706 -132,279 -95.18 117 -92.66 0.0000
2016-02-08 2015-09-30 13F/A-1 NANTKWEST COM 63016Q102 138,985 138,985 1,593 0.0006
2015-11-09 2015-09-30 13F NANTKWEST COM 63016Q102 138,985 1,593 0.0006
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.